Ivan Voitsekhovskiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ivan Voitsekhovskiy has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alma Nurtazina
Department of Epidemiology and Biostatistics, Semey Medical University, Semey 071400, Kazakhstan
4 shared publications - Daulet Dautov
Department of Propaedeutics of Internal Diseases, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan, Kazakhstan
4 shared publications - Maxat Toishimanov
Kazakhstan-Japan Innovative Center, Kazakh National Agrarian Research University, Almaty 050010, Kazakhstan
4 shared publications - Bakyt Kanapiyanov
Research group, Grant # AP14871855, Semey Medical University, Semey, Kazakhstan, Kazakhstan
3 shared publications - Kairat Karibayev
Central Clinical Hospital, Almaty 050040, Kazakhstan, Kazakhstan
3 shared publications - Yerbol Smail
Department of Infectious Diseases, Dermatovenereology and Immunology, NJSC Semey Medical University, Semey 071400, Kazakhstan
3 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (8) , 425
LC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome
Background: Metabolic syndrome (MetS) is a heterogeneous cardiometabolic group of conditions in which early disturbances of glucose homeostasis are not always adequately captured by routine clinical tests. Methods: In this pilot study, liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based blood serum peptidomics was applied to identify circulating peptide signatures associated with MetS and progressive glycemic impairment. Serum samples from healthy donors and patients with MetS, including subgroups with normoglycemia, prediabetes, and diabetes mellitus, were subjected to peptide enrichment by ultrafiltration and solid-phase extraction prior to LC-MS/MS analysis. Results: Overall, 6754 unique peptides derived from 1820 precursor proteins were identified, and 32 peptides were significantly overrepresented in patients with MetS relative to healthy donors. Eight precursor proteins and five identified peptides showed significant positive correlations with glycemic stage, likely indicating progressive remodeling of the circulating serum peptidome during disease progression. A separate analysis of patients with prediabetes revealed additional candidate markers associated with early metabolic alterations. Moreover, multivariate logistic regression identified a four-peptide panel with good discriminatory performance for differentiating healthy donors from patients with MetS, yielding a leave-one-out cross-validated area under the curve of 0.91. Conclusions: Collectively, these findings indicate that serum peptidome profiling can reveal biologically and clinically relevant possible candidate biomarkers associated with MetS and early dysglycemia.
- 11 August 2026
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (8) , 425
Open AccessLC-MS/MS Profiling of Blood Serum Reveals Disease-Enriched Peptides in Metabolic Syndrome
Background: Metabolic syndrome (MetS) is a heterogeneous cardiometabolic group of conditions in which early disturbances of glucose homeostasis are not always adequately captured by routine clinical tests. Methods: In this pilot study, liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based blood serum peptidomics was applied to identify circulating peptide signatures associated with MetS and progressive glycemic impairment. Serum samples from healthy donors and patients with MetS, including subgroups with normoglycemia, prediabetes, and diabetes mellitus, were subjected to peptide enrichment by ultrafiltration and solid-phase extraction prior to LC-MS/MS analysis. Results: Overall, 6754 unique peptides derived from 1820 precursor proteins were identified, and 32 peptides were significantly overrepresented in patients with MetS relative to healthy donors. Eight precursor proteins and five identified peptides showed significant positive correlations with glycemic stage, likely indicating progressive remodeling of the circulating serum peptidome during disease progression. A separate analysis of patients with prediabetes revealed additional candidate markers associated with early metabolic alterations. Moreover, multivariate logistic regression identified a four-peptide panel with good discriminatory performance for differentiating healthy donors from patients with MetS, yielding a leave-one-out cross-validated area under the curve of 0.91. Conclusions: Collectively, these findings indicate that serum peptidome profiling can reveal biologically and clinically relevant possible candidate biomarkers associated with MetS and early dysglycemia.
- Open Access
- 27 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (23) , 7206
Exploring the Link Between Vitamin B Levels and Metabolic Syndrome Risk: Insights from a Case-Control Study in Kazakhstan
Background/Objectives: Metabolic syndrome (MS) is a collection of metabolic disorders that include insulin resistance, central obesity, dyslipidemia, and hypertension. The prevalence of MS affects 20–30% of adults worldwide, leading to serious health, social, and economic issues. Mitochondrial dysfunction, characterized by mitochondrial DNA (mtDNA) mutations and altered dynamics, plays a pivotal role in MS by impairing glucose oxidation. B vitamins are crucial for optimal mitochondrial function and overall metabolic processes, particularly within the context of MS. This study aims to investigate the associations between plasma concentrations of B vitamins and the risk of MS within the Kazakh population. Methods: In this case-control study, biochemistry measurements included serum fasting glucose, HbA1c, creatinine, and lipid profile parameters. The sample comprised individuals who agreed to participate in the investigation and at the Semey polyclinic between December 2022 to March 2024. A total of 190 Kazakhs aged 35–65 years old, including 104 subjects with MS and 86 without MS, took part in the study. Results: In a comparative analysis of serum vitamin B levels against established reference ranges, the following results were observed: 95% of participants exhibited vitamin B2 levels at the lower limit of normal, while 4.59% were classified as low. For vitamin B3, 95.77% showed low levels, with only 4.23% in the normal range. Vitamin B6 levels were low in 76.02% of participants. In contrast, 92.82% had normal serum levels of vitamin B9. Regarding vitamin B12, 38.82% had normal levels, 59.41% had elevated levels, and 1.76% were classified as low. Among the evaluated vitamins, only vitamin B2 showed a significant correlation with the risk of developing MS, with an OR of 1.79 (95% CI 1.003, 3.19, p = 0.05). Conclusions: Relatively elevated serum levels of vitamin B2 at the lower limit of the normal range are associated with a 1.8-fold increased risk of developing MS.
- 27 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (23) , 7206
Open AccessExploring the Link Between Vitamin B Levels and Metabolic Syndrome Risk: Insights from a Case-Control Study in Kazakhstan
Background/Objectives: Metabolic syndrome (MS) is a collection of metabolic disorders that include insulin resistance, central obesity, dyslipidemia, and hypertension. The prevalence of MS affects 20–30% of adults worldwide, leading to serious health, social, and economic issues. Mitochondrial dysfunction, characterized by mitochondrial DNA (mtDNA) mutations and altered dynamics, plays a pivotal role in MS by impairing glucose oxidation. B vitamins are crucial for optimal mitochondrial function and overall metabolic processes, particularly within the context of MS. This study aims to investigate the associations between plasma concentrations of B vitamins and the risk of MS within the Kazakh population. Methods: In this case-control study, biochemistry measurements included serum fasting glucose, HbA1c, creatinine, and lipid profile parameters. The sample comprised individuals who agreed to participate in the investigation and at the Semey polyclinic between December 2022 to March 2024. A total of 190 Kazakhs aged 35–65 years old, including 104 subjects with MS and 86 without MS, took part in the study. Results: In a comparative analysis of serum vitamin B levels against established reference ranges, the following results were observed: 95% of participants exhibited vitamin B2 levels at the lower limit of normal, while 4.59% were classified as low. For vitamin B3, 95.77% showed low levels, with only 4.23% in the normal range. Vitamin B6 levels were low in 76.02% of participants. In contrast, 92.82% had normal serum levels of vitamin B9. Regarding vitamin B12, 38.82% had normal levels, 59.41% had elevated levels, and 1.76% were classified as low. Among the evaluated vitamins, only vitamin B2 showed a significant correlation with the risk of developing MS, with an OR of 1.79 (95% CI 1.003, 3.19, p = 0.05). Conclusions: Relatively elevated serum levels of vitamin B2 at the lower limit of the normal range are associated with a 1.8-fold increased risk of developing MS.
- Open Access
- 14 October 2024
- Published by MDPI AG in Preprints.org
Exploring the Link between Vitamin B Levels and Metabolic Syndrome Risk: Insights from a Case-Control Study in Kazakhstan
This research is funded by the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (grant AP14871855).
- 14 October 2024
- Published by MDPI AG in Preprints.org
Open AccessExploring the Link between Vitamin B Levels and Metabolic Syndrome Risk: Insights from a Case-Control Study in Kazakhstan
This research is funded by the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (grant AP14871855).
- Open Access
- 30 August 2024
- Published by MDPI AG in Preprints.org
Associations of Amino Acids with the Risk of Prediabetes: a Case-Control Study from Kazakhstan
Background: The high global prevalence of prediabetes requires its early identification. Amino acids have emerged as potential predictors of prediabetes. This study aims to investigate the association between BCAAs and prediabetes in the Kazakh population. Materials and Methods: In this case-control study, plasma BCAAs levels were measured using the Trace GC 1310 gas chromatography system coupled with the TSQ 8000 triple quadrupole mass spectrometer (Thermo Scientific, Austin, TX, USA) followed by silylation with the BSTFA + 1% TMCS derivatization method. Biochemical parameters, including total cholesterol, HDL-C, LDL-C, triglycerides, fasting glucose, HbA1c, and creatinine, were assessed for each participant. Anthropometric and physical examinations, including blood pressure, heart rate measurements, and family history collection, were conducted by trained professionals. Results: The final analysis included data from 112 Kazakhs with prediabetes and 55 without prediabetes, aged 36-65 years. Of the thirteen AAs analyzed, only alanine showed a significant association with prediabetes risk. Our findings revealed an inverse relationship between alanine and aspartic acid levels, and direct association of lysine and prediabetes in Kazakh ethnicity. Conclusion: Lower plasma level of alanine and aspartic acid, and higher level of lysine may serve as predictive biomarkers for prediabetes in the Kazakh population. This research is funded by the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (grant AP14871855).
- 30 August 2024
- Published by MDPI AG in Preprints.org
Open AccessAssociations of Amino Acids with the Risk of Prediabetes: a Case-Control Study from Kazakhstan
Background: The high global prevalence of prediabetes requires its early identification. Amino acids have emerged as potential predictors of prediabetes. This study aims to investigate the association between BCAAs and prediabetes in the Kazakh population. Materials and Methods: In this case-control study, plasma BCAAs levels were measured using the Trace GC 1310 gas chromatography system coupled with the TSQ 8000 triple quadrupole mass spectrometer (Thermo Scientific, Austin, TX, USA) followed by silylation with the BSTFA + 1% TMCS derivatization method. Biochemical parameters, including total cholesterol, HDL-C, LDL-C, triglycerides, fasting glucose, HbA1c, and creatinine, were assessed for each participant. Anthropometric and physical examinations, including blood pressure, heart rate measurements, and family history collection, were conducted by trained professionals. Results: The final analysis included data from 112 Kazakhs with prediabetes and 55 without prediabetes, aged 36-65 years. Of the thirteen AAs analyzed, only alanine showed a significant association with prediabetes risk. Our findings revealed an inverse relationship between alanine and aspartic acid levels, and direct association of lysine and prediabetes in Kazakh ethnicity. Conclusion: Lower plasma level of alanine and aspartic acid, and higher level of lysine may serve as predictive biomarkers for prediabetes in the Kazakh population. This research is funded by the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan (grant AP14871855).